Cancer Venous Thromboembolism (VTE)

NCT02073682 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1046

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism (VTE)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Cancer

Interventions

DRUG: Edoxaban
DRUG: Dalteparin
DRUG: Low molecular weight heparin

Sponsor

Daiichi Sankyo